| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.9M | +287.9% |
| Cost of Revenue | $10.3M | +361.9% |
| Gross Profit | $8.6M | +225.2% |
| R&D Expense | $3.9M | +20.5% |
| SG&A Expense | $9.1M | -21.3% |
| Operating Income | -$4.4M | +63.6% |
| Pre-tax Income | -$21.1M | -134.2% |
| Income Tax | -$1K | +93.7% |
| Net Income | -$21.1M | -134.6% |
| EPS (Basic) | -$2.01 | -183.1% |
| EPS (Diluted) | -$2.01 | -183.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.4M | +788.4% |
| Accounts Receivable | $5.8M | +8513.1% |
| Inventory | $5.0M | +60.1% |
| Current Assets | $22.1M | +349.3% |
| Total Assets | $23.0M | +278.2% |
| Current Liabilities | $7.9M | -19.7% |
| Long-term Debt | $10.1M | +1.8% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.0M | +10.7% |
| Capital Expenditures | $124K | +41.2% |
| Investing Cash Flow | -$124K | -41.2% |
| Financing Cash Flow | $18.4M | +64.9% |
| Free Cash Flow | -$9.1M | +10.3% |
| $16.6M |
| +6.1% |
| Stockholders' Equity | $6.4M | +167.6% |